EL219, Active Comparator- IV Antifungal (LAmB or voriconazole) — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 2mo
ESTIMATED |
READOUT
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifung
Phase 2 · Invasive Mould Infection |
Elion Therapeutics, Inc. | EL219, Active Comparator- IV Antifungal |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|